October 17, 2008
iCAD Inc. (ICAD) President and Chief Executive Officer to Ring the NASDAQ Stock Market Closing Bell
ADVISORY, Oct. 17, 2008 (GLOBE NEWSWIRE) --
What: Ken Ferry, President and Chief Executive Officer of iCAD Inc. (ICAD), and the executive management team, will preside over the Closing Bell in recognition of Breast Cancer Awareness Month. iCAD, an industry-leading provider of Computer-Aided Detection (CAD) solutions for the early identification of cancer, is committed to helping clinicians find the most prevalent cancers, including breast, colon and prostate cancer, earlier, faster and with greater confidence. Where: NASDAQ MarketSite - 4 Times Square - 43rd & Broadway - Broadcast Studio When: Monday, October 20, 2008 at 3:45 - 4:00 p.m. ET Contacts: Public Relations: Meara Murphy Manning Selvage & Lee (617) 937-2574 [email protected] iCAD Inc.: Darlene Deptula-Hicks Executive Vice President and Chief Financial Officer 603-882-5200 x7944 [email protected] NASDAQ MarketSite: Robert Madden 646.441.5045 [email protected]
The Closing Bell is available from 3:50 p.m. to 4:05 p.m. on AMC-3/C-3 (ul 5985V; dl 3760H) The feed can also be found on Ascent fiber 1623. If you have any questions, please contact Robert Madden at (646) 441-5045.
An audio transmission of the Closing Bell is also available from 3:50 p.m. to 4:05 p.m. on uplink IA6 C band / transponder 24, downlink frequency 4180 horizontal. The feed can be found on Ascent fiber 1623 as well.
A live Webcast of the NASDAQ Closing Bell will be available at: http://www.nasdaq.com/about/marketsitetowervideo.asx
To obtain a hi-resolution photograph of the Market Close, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market close of your choice.
About iCAD Inc. (ICAD):
iCAD, Inc. is an industry-leading provider of Computer-Aided Detection (CAD) solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing cancer earlier. iCAD offers a comprehensive range of high-performance, upgradeable CAD systems and workflow solutions for mammography (film-based, digital radiography (DR) and computed radiography (CR)), Magnetic Resonance Imaging (MRI), and Computed Tomography (CT). Currently available in more than 2,200 healthcare centers worldwide, iCAD's solutions aid in the early detection of the most prevalent cancers, including breast, colon, prostate, and, in the future, lung cancer. For more information, call (877) iCADnow or visit www.icadmed.com.
About NASDAQ OMX:
The NASDAQ OMX Group, Inc. is the world's largest exchange company. It delivers trading, exchange technology and public company services across six continents, and with over 3,900 companies, it is number one in worldwide listings among major markets. NASDAQ OMX offers multiple capital raising solutions to companies around the globe, including its U.S. listings market; the OMX Nordic Exchange, including First North; and the 144A PORTAL Market. The company offers trading across multiple asset classes including equities, derivatives, debt, commodities, structured products and ETFs. NASDAQ OMX technology supports the operations of over 60 exchanges, clearing organizations and central securities depositories in more than 50 countries. OMX Nordic Exchange is not a legal entity but describes the common offering from NASDAQ OMX exchanges in Helsinki, Copenhagen, Stockholm, Iceland, Tallinn, Riga, and Vilnius. For more information about NASDAQ OMX, visit http://www.nasdaqomx.com/.
This news release was distributed by GlobeNewswire, www.globenewswire.com